Insulin syringe, fixed-needle
Australia TGA ARTG Registered Device · B Braun Australia Pty Ltd · Feel Tech Bio Co Ltd · Class IIa · Started May 20, 2020
Good Name: B Braun Australia Pty Ltd - Insulin syringe, fixed-needle
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- May 20, 2020
- Effective Date
- May 20, 2020
- Country
- South Korea
- Address
- 1079-20 Charyeonggogae-ro Gwangdoek-myeon Cheonan-si, Dongnam-gu, Chungcheongnam-do, 31223
Single-use insulin syringe with integrated needle
Access comprehensive regulatory information for Insulin syringe, fixed-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by B Braun Australia Pty Ltd, manufactured by Feel Tech Bio Co Ltd in South Korea. The device registration started on May 20, 2020.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.